Snapshot

The EMA Marketing Authorisation under Exceptional Circumstances pathway has been developed by the European Medicines Agency of EU-EMA.

It is an abridged review (a reliance pathway).

Regional regulatory initiatives can help optimize the efficient use of an agency’s resources. The following countries participate in this initiative/pathway: EU-EMA

Info not found